Results 281 to 290 of about 214,937 (381)

Auto-immune gastritis induced by pembrolizumab, an anti-PD-1, in a melanoma patient.

open access: green, 2020
Julie Vandepapeliere   +5 more
openalex   +1 more source

Lobeglitazone improves glycaemic control as add‐on therapy to empagliflozin plus metformin in patients with type 2 diabetes mellitus: A double‐blind, randomised, placebo‐controlled trial

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 1, Page 728-740, January 2026.
Abstract Aims This study aimed to evaluate the efficacy and safety of triple therapy with lobeglitazone 0.5 mg as an add‐on treatment compared with placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled with metformin and empagliflozin.
Da Hea Seo   +8 more
wiley   +1 more source

Subtypes of chronic gastritis in patients with celiac disease before and after gluten-free diet

open access: yesUnited European Gastroenterology journal, 2017
D. Gabrieli   +11 more
semanticscholar   +1 more source

A review for the prevention and management of Helicobacter pylori induced gastritis through development of novel vaccine candidates

open access: diamond
Sanjib Das   +5 more
openalex   +1 more source

Further Insights Into Anticholinergic Action Informed by Japanese Anticholinergic Risk Scale

open access: yesGeriatrics &Gerontology International, Volume 26, Issue 1, January 2026.
ABSTRACT The increased anticholinergic burden caused by medications in older adults is one of the adverse drug reactions of particular concern, as it can exacerbate the onset of geriatric syndromes or induce cognitive dysfunction, and is also related to the issue of polypharmacy.
Masaki Mogi   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy